Fundraising Fox
Cognoptix
Boston, US · 3 known investors
Find your way into Cognoptix
2,313 people in our graph share verified history with the Cognoptix team — schools, employers, funds. One of them is your warm intro.
Job Simonunlockedknows Paul Hartung · together at 3Com (overlapped)
×2knows the team · via 3Com
×3knows the team · via Motorola
×2knows the team · via GE
knows the team · via Neutron Therapeutics, Inc.
knows the team · via Summit Technology
Cognoptix develops the Sapphire II system, a non-invasive laser eye scanning device paired with an eye ointment that binds to beta amyloid proteins in the lens of the eye to aid early detection and diagnosis of Alzheimer's disease. The company builds diagnostic devices and agents for clinical, commercial, and academic research use and works with pharma partners and academic institutes.
Founders & leadership
DL
Dr. Lee GoldsteinCo-founder
DL
Dr. Leo ChylackCo-founder
SW
Susanne WilkePresident & CEOSusanne Wilke is President and CEO of Cognoptix, which develops diagnostic devices for early detection of Alzheimer's disease, and previously served in leadership roles at other biotechnology companies including Neurotrope.
CH
Carl H. SadowskyChief Medical OfficerCarl Sadowsky is Chief Medical Officer at Cognoptix and has led clinical trials in Alzheimer's disease research since 2010, including studies on amyloid biomarkers and multiple approved AD therapeutics. He holds an MD from Weill Medical College of Cornell University, completed neurology and internal medicine residencies at Dartmouth-Hitchcock Medical Center, and previously served as Chief of Neurology at the U.S. Air Force Hospital in Wiesbaden, Germany.
MK
Mike KaswanChief Financial Officer
PH
Paul HartungChairman, President & CEO2004–2015Paul Hartung is Chairman, President and CEO of Cognoptix, which develops a non-invasive laser eye scanning system for early detection of Alzheimer's disease. He holds an MS in Mechanical Engineering from MIT and has held executive roles in the medical device and technology sectors at companies including GE, 3Com, and Motorola, as well as founding roles at Summit and Winphoria.
TT
Tom TrometerExecutive
GD
Gerald D. CagleExecutive
Board
GW
Gunnar WeikertBoard director
WS
Werner SchaeferBoard director
RG
Richard GillBoard director
Investors · 3
AEON Foundrylisted by AEON FoundryNew York City
How we know: AEON Foundry's portfolio page · Not right? Tell us
Boston Harbor Angelslisted by Boston Harbor AngelsBoston · $250K – $1.5M
How we know: Boston Harbor Angels's portfolio page · Not right? Tell us
Launchpad Venture GroupreportedBoston · $8M – $10M
How we know: funding news · press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$13M disclosed across 2 rounds · 2014
▶$12.6MraisedOct 2014 · 32 investors · Other TechnologyRule 506(b)
▶$12.6MraisedOct 2014 · 32 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Christine de los ReyesDirector
- Tom TrometerExecutive Officer
- Paul HartungExecutive Officer, Director
- Gunnar WeikertDirector
- Offering amount
- $15.6M
- Amount sold
- $12.6M
- Sales commissions
- $405K
- Placement agents
- Robert W. Baird & Co. Incorporated
- First sale
- Sep 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$390KraisedApr 2014 · 22 investors · Other TechnologyRule 506(b)
▶$390KraisedApr 2014 · 22 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Paul HartungExecutive Officer, Director
- Gunnar WeikertDirector
- Tom TrometerExecutive Officer
- Gerald D. CagleExecutive Officer
- Werner SchaeferDirector
- Richard GillDirector
- Offering amount
- $1.5M
- Amount sold
- $390K
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Cognoptix do?
- Cognoptix develops the Sapphire II system, a non-invasive laser eye scanning device paired with an eye ointment that binds to beta amyloid proteins in the lens of the eye to aid early detection and diagnosis of Alzheimer's disease. The company builds diagnostic devices and agents for clinical, commercial, and academic research use and works with pharma partners and academic institutes.
- Who founded Cognoptix?
- Cognoptix was founded by Dr. Lee Goldstein, Dr. Leo Chylack.
- Who are Cognoptix's investors?
- Cognoptix's investors include AEON Foundry, Boston Harbor Angels, Launchpad Venture Group.
- How much funding has Cognoptix raised?
- Cognoptix has disclosed $13M raised across 2 rounds.
- Where is Cognoptix headquartered?
- Cognoptix is headquartered in Boston, US.